Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizophrenia | 58 | 2024 | 6929 | 2.270 |
Why?
|
Tobacco Use Disorder | 13 | 2024 | 703 | 1.780 |
Why?
|
Smoking Cessation | 21 | 2024 | 2056 | 1.770 |
Why?
|
Psychotic Disorders | 29 | 2024 | 3220 | 1.600 |
Why?
|
Antipsychotic Agents | 20 | 2024 | 3067 | 0.870 |
Why?
|
Mental Disorders | 11 | 2024 | 6826 | 0.810 |
Why?
|
Community-Based Participatory Research | 1 | 2023 | 221 | 0.740 |
Why?
|
Family Therapy | 2 | 2019 | 215 | 0.690 |
Why?
|
Trust | 1 | 2023 | 529 | 0.610 |
Why?
|
Schizophrenic Psychology | 16 | 2017 | 1646 | 0.600 |
Why?
|
Bupropion | 8 | 2022 | 304 | 0.580 |
Why?
|
Needs Assessment | 1 | 2023 | 1139 | 0.560 |
Why?
|
Cycloserine | 5 | 2020 | 118 | 0.550 |
Why?
|
Substance-Related Disorders | 5 | 2022 | 4416 | 0.540 |
Why?
|
Tobacco Use Cessation | 3 | 2023 | 94 | 0.530 |
Why?
|
Delusions | 5 | 2022 | 298 | 0.490 |
Why?
|
Evidence-Based Practice | 1 | 2019 | 494 | 0.490 |
Why?
|
Smoking | 9 | 2024 | 9054 | 0.480 |
Why?
|
Mental Health Services | 2 | 2023 | 1717 | 0.460 |
Why?
|
Clozapine | 10 | 2024 | 504 | 0.430 |
Why?
|
Nicotinic Agonists | 7 | 2018 | 265 | 0.420 |
Why?
|
Quinolones | 3 | 2010 | 378 | 0.400 |
Why?
|
Cannabis | 3 | 2022 | 441 | 0.380 |
Why?
|
Nicotine | 7 | 2022 | 679 | 0.370 |
Why?
|
Morgellons Disease | 1 | 2010 | 4 | 0.370 |
Why?
|
Antimetabolites | 3 | 2020 | 129 | 0.340 |
Why?
|
Piperazines | 4 | 2010 | 2521 | 0.280 |
Why?
|
Bipolar Disorder | 7 | 2023 | 5091 | 0.250 |
Why?
|
Hallucinations | 3 | 2023 | 366 | 0.250 |
Why?
|
HIV Seropositivity | 1 | 2010 | 959 | 0.240 |
Why?
|
Psychotherapy, Brief | 1 | 2005 | 118 | 0.230 |
Why?
|
Social Behavior | 3 | 2010 | 1135 | 0.210 |
Why?
|
Humans | 91 | 2024 | 760740 | 0.200 |
Why?
|
Combined Modality Therapy | 8 | 2020 | 8516 | 0.200 |
Why?
|
Depressive Disorder, Major | 5 | 2023 | 4764 | 0.190 |
Why?
|
Psychology, Clinical | 1 | 2022 | 42 | 0.190 |
Why?
|
Risperidone | 4 | 2013 | 381 | 0.190 |
Why?
|
Psychiatric Status Rating Scales | 12 | 2022 | 6016 | 0.190 |
Why?
|
Adult | 52 | 2024 | 220995 | 0.180 |
Why?
|
Citalopram | 3 | 2023 | 402 | 0.170 |
Why?
|
Mental Health | 4 | 2023 | 3253 | 0.170 |
Why?
|
Benzodiazepines | 5 | 2009 | 1133 | 0.170 |
Why?
|
Social Stigma | 2 | 2023 | 769 | 0.170 |
Why?
|
Double-Blind Method | 19 | 2020 | 12333 | 0.160 |
Why?
|
Depression | 2 | 2017 | 8132 | 0.160 |
Why?
|
Weight Gain | 4 | 2023 | 2349 | 0.150 |
Why?
|
Internet | 1 | 2010 | 3094 | 0.150 |
Why?
|
Dopamine Uptake Inhibitors | 3 | 2005 | 297 | 0.150 |
Why?
|
Cooperative Behavior | 2 | 2023 | 1505 | 0.150 |
Why?
|
Substance Withdrawal Syndrome | 3 | 2018 | 625 | 0.150 |
Why?
|
Implosive Therapy | 1 | 2018 | 125 | 0.140 |
Why?
|
Mental Recall | 2 | 2022 | 1222 | 0.140 |
Why?
|
Peer Group | 1 | 2022 | 692 | 0.130 |
Why?
|
Cognition Disorders | 7 | 2014 | 3979 | 0.130 |
Why?
|
Male | 54 | 2024 | 360402 | 0.130 |
Why?
|
Cyclobutanes | 2 | 2007 | 57 | 0.130 |
Why?
|
Self Concept | 1 | 2022 | 1046 | 0.130 |
Why?
|
Appetite Depressants | 2 | 2007 | 108 | 0.130 |
Why?
|
Patient Dropouts | 1 | 2017 | 410 | 0.120 |
Why?
|
Middle Aged | 38 | 2024 | 220603 | 0.120 |
Why?
|
Treatment Outcome | 18 | 2021 | 64572 | 0.120 |
Why?
|
Hippocampus | 3 | 2023 | 3762 | 0.120 |
Why?
|
Female | 52 | 2024 | 392203 | 0.120 |
Why?
|
Play Therapy | 1 | 2013 | 17 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1110 | 0.110 |
Why?
|
Benzhydryl Compounds | 2 | 2011 | 915 | 0.110 |
Why?
|
Motivation | 2 | 2021 | 2003 | 0.110 |
Why?
|
Social Support | 4 | 2024 | 2174 | 0.100 |
Why?
|
Pravastatin | 1 | 2014 | 392 | 0.100 |
Why?
|
Age of Onset | 1 | 2019 | 3303 | 0.100 |
Why?
|
Blood Glucose | 6 | 2011 | 6390 | 0.100 |
Why?
|
Massachusetts | 2 | 2023 | 8835 | 0.100 |
Why?
|
Preventive Medicine | 1 | 2013 | 245 | 0.100 |
Why?
|
Behavior Therapy | 2 | 2015 | 877 | 0.090 |
Why?
|
Cluster Analysis | 1 | 2018 | 2703 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2024 | 3599 | 0.090 |
Why?
|
Central Nervous System Stimulants | 3 | 2009 | 1177 | 0.090 |
Why?
|
Religion | 2 | 2004 | 376 | 0.090 |
Why?
|
Social Adjustment | 2 | 2010 | 632 | 0.090 |
Why?
|
Cardiovascular Diseases | 5 | 2020 | 15498 | 0.090 |
Why?
|
Adolescent | 10 | 2022 | 88247 | 0.090 |
Why?
|
Mood Disorders | 1 | 2017 | 1127 | 0.090 |
Why?
|
Anxiety Disorders | 2 | 2022 | 2724 | 0.090 |
Why?
|
Self Report | 2 | 2018 | 3727 | 0.090 |
Why?
|
Young Adult | 11 | 2022 | 59191 | 0.080 |
Why?
|
Anecdotes as Topic | 1 | 2009 | 56 | 0.080 |
Why?
|
Cotinine | 2 | 2022 | 206 | 0.080 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 26065 | 0.080 |
Why?
|
Lipid Metabolism | 3 | 2014 | 1896 | 0.080 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2013 | 600 | 0.080 |
Why?
|
Psychotherapy | 2 | 2009 | 1648 | 0.080 |
Why?
|
Professional-Patient Relations | 2 | 2021 | 724 | 0.080 |
Why?
|
Alcoholism | 1 | 2018 | 1972 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2008 | 214 | 0.070 |
Why?
|
Anthropometry | 2 | 2009 | 1338 | 0.070 |
Why?
|
Body Weight | 5 | 2011 | 4615 | 0.070 |
Why?
|
Anticholesteremic Agents | 1 | 2014 | 967 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 2164 | 0.070 |
Why?
|
Pilot Projects | 5 | 2022 | 8619 | 0.070 |
Why?
|
Drug Therapy, Combination | 6 | 2018 | 6305 | 0.070 |
Why?
|
Malingering | 1 | 2006 | 75 | 0.070 |
Why?
|
Dibenzothiazepines | 1 | 2006 | 102 | 0.060 |
Why?
|
Psychotherapeutic Processes | 1 | 2006 | 51 | 0.060 |
Why?
|
Sulfones | 1 | 2008 | 447 | 0.060 |
Why?
|
Placebos | 5 | 2009 | 1667 | 0.060 |
Why?
|
Pedophilia | 1 | 2005 | 7 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2023 | 5430 | 0.060 |
Why?
|
Waist Circumference | 1 | 2009 | 933 | 0.060 |
Why?
|
Cognition | 2 | 2022 | 6988 | 0.060 |
Why?
|
Glucose | 4 | 2010 | 4345 | 0.060 |
Why?
|
Indans | 1 | 2005 | 92 | 0.060 |
Why?
|
Obesity | 8 | 2020 | 12934 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10203 | 0.060 |
Why?
|
Metabolic Diseases | 1 | 2011 | 680 | 0.060 |
Why?
|
Neuroprotective Agents | 1 | 2011 | 957 | 0.060 |
Why?
|
Delayed-Action Preparations | 5 | 2007 | 962 | 0.060 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2007 | 489 | 0.060 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2007 | 361 | 0.060 |
Why?
|
Students | 3 | 2022 | 1736 | 0.060 |
Why?
|
Hyperlipidemias | 2 | 2005 | 770 | 0.050 |
Why?
|
Quality of Life | 4 | 2022 | 13359 | 0.050 |
Why?
|
Health Status | 4 | 2009 | 4076 | 0.050 |
Why?
|
Neuropsychological Tests | 7 | 2009 | 7050 | 0.050 |
Why?
|
Homocysteine | 1 | 2006 | 637 | 0.050 |
Why?
|
Insulin Resistance | 4 | 2010 | 3954 | 0.050 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2010 | 940 | 0.050 |
Why?
|
Memory | 2 | 2008 | 2192 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8652 | 0.050 |
Why?
|
Dietary Fats | 1 | 2010 | 1995 | 0.050 |
Why?
|
Hazardous Substances | 1 | 2022 | 153 | 0.050 |
Why?
|
Attitude to Health | 3 | 2006 | 2025 | 0.050 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2021 | 109 | 0.050 |
Why?
|
Education, Graduate | 1 | 2022 | 75 | 0.050 |
Why?
|
Glucose Tolerance Test | 3 | 2010 | 1178 | 0.050 |
Why?
|
Affect | 1 | 2008 | 1486 | 0.050 |
Why?
|
Comorbidity | 6 | 2017 | 10507 | 0.040 |
Why?
|
Ambulatory Care | 3 | 2008 | 2768 | 0.040 |
Why?
|
Diabetes Mellitus | 4 | 2020 | 5838 | 0.040 |
Why?
|
Prescriptions | 1 | 2022 | 386 | 0.040 |
Why?
|
Analysis of Variance | 4 | 2011 | 6223 | 0.040 |
Why?
|
Models, Psychological | 1 | 2004 | 829 | 0.040 |
Why?
|
Carbon Monoxide | 2 | 2017 | 547 | 0.040 |
Why?
|
Morbidity | 1 | 2005 | 1750 | 0.040 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 4 | 2008 | 1988 | 0.040 |
Why?
|
Electroconvulsive Therapy | 1 | 2024 | 500 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2315 | 0.040 |
Why?
|
Follow-Up Studies | 9 | 2016 | 39062 | 0.040 |
Why?
|
Prospective Studies | 3 | 2021 | 54364 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2022 | 1575 | 0.040 |
Why?
|
Energy Intake | 1 | 2006 | 2133 | 0.040 |
Why?
|
Family | 1 | 2009 | 3193 | 0.040 |
Why?
|
Oxidative Stress | 2 | 2021 | 3115 | 0.040 |
Why?
|
Pyrenes | 1 | 2017 | 49 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5334 | 0.030 |
Why?
|
Piperidines | 1 | 2005 | 1655 | 0.030 |
Why?
|
Nitrosamines | 1 | 2017 | 87 | 0.030 |
Why?
|
China | 1 | 2023 | 2374 | 0.030 |
Why?
|
Attention | 3 | 2017 | 2396 | 0.030 |
Why?
|
Aged | 13 | 2022 | 169092 | 0.030 |
Why?
|
Child | 3 | 2019 | 80089 | 0.030 |
Why?
|
Activities of Daily Living | 3 | 2013 | 2419 | 0.030 |
Why?
|
Atrophy | 1 | 2021 | 1632 | 0.030 |
Why?
|
Housing | 1 | 2021 | 669 | 0.030 |
Why?
|
Community Mental Health Centers | 2 | 2006 | 93 | 0.030 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2005 | 1492 | 0.030 |
Why?
|
Pennsylvania | 1 | 2017 | 612 | 0.030 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1996 | 310 | 0.030 |
Why?
|
Polydactyly | 1 | 1995 | 56 | 0.030 |
Why?
|
National Institute of Mental Health (U.S.) | 1 | 2015 | 107 | 0.030 |
Why?
|
Smoke | 1 | 2017 | 236 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2004 | 2188 | 0.030 |
Why?
|
Prader-Willi Syndrome | 1 | 1995 | 78 | 0.030 |
Why?
|
Emotions | 2 | 2022 | 2741 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2005 | 5239 | 0.030 |
Why?
|
Body Mass Index | 6 | 2009 | 12942 | 0.030 |
Why?
|
Cholesterol | 3 | 2009 | 2902 | 0.030 |
Why?
|
Blood Pressure | 3 | 2020 | 8473 | 0.030 |
Why?
|
Feeding Behavior | 1 | 2006 | 3183 | 0.030 |
Why?
|
Genetic Linkage | 2 | 1996 | 2340 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3117 | 0.030 |
Why?
|
Cues | 1 | 2018 | 875 | 0.030 |
Why?
|
Education, Special | 1 | 2013 | 86 | 0.030 |
Why?
|
Family Conflict | 1 | 2013 | 95 | 0.030 |
Why?
|
Nutrition Assessment | 2 | 2006 | 726 | 0.030 |
Why?
|
Schools | 1 | 2021 | 1483 | 0.030 |
Why?
|
Psychiatry | 1 | 2005 | 1693 | 0.030 |
Why?
|
Family Health | 2 | 2013 | 1253 | 0.020 |
Why?
|
Psychology | 2 | 2004 | 356 | 0.020 |
Why?
|
Time Factors | 5 | 2016 | 39908 | 0.020 |
Why?
|
Cost of Illness | 2 | 2013 | 1937 | 0.020 |
Why?
|
Child, Hospitalized | 1 | 2013 | 182 | 0.020 |
Why?
|
Quinoxalines | 1 | 2014 | 296 | 0.020 |
Why?
|
Benzazepines | 1 | 2014 | 310 | 0.020 |
Why?
|
Behavioral Symptoms | 1 | 2013 | 186 | 0.020 |
Why?
|
Probability | 1 | 2016 | 2475 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 3708 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1436 | 0.020 |
Why?
|
Hypertension | 3 | 2020 | 8532 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2008 | 4845 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 1996 | 4611 | 0.020 |
Why?
|
Drug Synergism | 1 | 2014 | 1756 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2008 | 4575 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2391 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3370 | 0.020 |
Why?
|
Triglycerides | 2 | 2009 | 2459 | 0.020 |
Why?
|
Hypogonadism | 1 | 1995 | 798 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2024 | 80583 | 0.020 |
Why?
|
Lipids | 1 | 2020 | 3332 | 0.020 |
Why?
|
Polymethacrylic Acids | 1 | 2008 | 32 | 0.020 |
Why?
|
Chewing Gum | 1 | 2008 | 40 | 0.020 |
Why?
|
Trail Making Test | 1 | 2008 | 57 | 0.020 |
Why?
|
Outpatients | 1 | 2017 | 1596 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2004 | 3621 | 0.020 |
Why?
|
Psychomotor Performance | 2 | 2008 | 1882 | 0.020 |
Why?
|
Parents | 1 | 2022 | 3563 | 0.020 |
Why?
|
Los Angeles | 1 | 2009 | 244 | 0.020 |
Why?
|
Case Management | 1 | 2010 | 272 | 0.020 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2009 | 303 | 0.020 |
Why?
|
Life Style | 1 | 2020 | 3907 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2017 | 1661 | 0.020 |
Why?
|
Diet Records | 1 | 2010 | 427 | 0.020 |
Why?
|
Inflammation | 2 | 2021 | 10759 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3739 | 0.020 |
Why?
|
United States | 4 | 2022 | 72292 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 2013 | 888 | 0.020 |
Why?
|
Polyvinyls | 1 | 2008 | 154 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2005 | 7390 | 0.020 |
Why?
|
Culture | 1 | 2011 | 623 | 0.020 |
Why?
|
Alcohol-Related Disorders | 1 | 2009 | 238 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2008 | 712 | 0.020 |
Why?
|
Food Preferences | 1 | 2010 | 398 | 0.020 |
Why?
|
Self Efficacy | 1 | 2010 | 636 | 0.020 |
Why?
|
Sialorrhea | 1 | 2005 | 25 | 0.020 |
Why?
|
Risk Factors | 5 | 2020 | 74128 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3805 | 0.020 |
Why?
|
Capsules | 1 | 2005 | 191 | 0.020 |
Why?
|
Obesity, Morbid | 1 | 1996 | 1276 | 0.020 |
Why?
|
Purines | 1 | 2008 | 606 | 0.020 |
Why?
|
Dyskinesias | 1 | 2005 | 79 | 0.020 |
Why?
|
Pyridines | 1 | 2017 | 2875 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 10754 | 0.010 |
Why?
|
Periodicity | 1 | 2006 | 347 | 0.010 |
Why?
|
Waist-Hip Ratio | 1 | 2006 | 518 | 0.010 |
Why?
|
Cause of Death | 2 | 2005 | 3683 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2023 | 36401 | 0.010 |
Why?
|
Sex Factors | 2 | 2010 | 10549 | 0.010 |
Why?
|
Basal Ganglia Diseases | 1 | 2004 | 145 | 0.010 |
Why?
|
Sample Size | 1 | 2007 | 838 | 0.010 |
Why?
|
Cholinesterase Inhibitors | 1 | 2005 | 242 | 0.010 |
Why?
|
Exercise | 1 | 2020 | 5886 | 0.010 |
Why?
|
Eating | 1 | 2010 | 1535 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2010 | 1835 | 0.010 |
Why?
|
Life Change Events | 1 | 2008 | 953 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2009 | 2079 | 0.010 |
Why?
|
Personality Inventory | 1 | 2006 | 1018 | 0.010 |
Why?
|
Disease Management | 1 | 2013 | 2506 | 0.010 |
Why?
|
Stereotyping | 1 | 2004 | 239 | 0.010 |
Why?
|
Wakefulness | 1 | 2009 | 1264 | 0.010 |
Why?
|
Fatigue | 1 | 2009 | 1550 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2022 | 58919 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2007 | 745 | 0.010 |
Why?
|
Caffeine | 1 | 2006 | 699 | 0.010 |
Why?
|
Insulin | 2 | 2006 | 6593 | 0.010 |
Why?
|
Proteins | 1 | 1996 | 6030 | 0.010 |
Why?
|
Decision Making | 1 | 2015 | 3919 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2007 | 12966 | 0.010 |
Why?
|
Hemoglobins | 1 | 2007 | 1524 | 0.010 |
Why?
|
Fasting | 1 | 2007 | 1603 | 0.010 |
Why?
|
Awareness | 1 | 2004 | 649 | 0.010 |
Why?
|
Prediabetic State | 1 | 2006 | 545 | 0.010 |
Why?
|
Prevalence | 2 | 2007 | 15702 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2006 | 1987 | 0.010 |
Why?
|
Reaction Time | 1 | 2006 | 2087 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2006 | 2358 | 0.010 |
Why?
|
Learning | 1 | 2008 | 1740 | 0.010 |
Why?
|
Folic Acid | 1 | 2006 | 1323 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4919 | 0.010 |
Why?
|
Employment | 1 | 2004 | 1113 | 0.010 |
Why?
|
Urban Population | 1 | 2006 | 2034 | 0.010 |
Why?
|
Overweight | 1 | 2009 | 2417 | 0.010 |
Why?
|
Nutritional Status | 1 | 2006 | 1597 | 0.010 |
Why?
|
Primary Prevention | 1 | 2005 | 1185 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2009 | 3820 | 0.010 |
Why?
|
Communicable Diseases | 1 | 2005 | 871 | 0.010 |
Why?
|
Disease Progression | 1 | 2013 | 13495 | 0.010 |
Why?
|
Regression Analysis | 1 | 2006 | 6339 | 0.010 |
Why?
|
Boston | 1 | 2009 | 9313 | 0.010 |
Why?
|
Psychometrics | 1 | 2006 | 3062 | 0.010 |
Why?
|
Prognosis | 2 | 2007 | 29601 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12043 | 0.010 |
Why?
|
Nuclear Family | 1 | 1996 | 311 | 0.010 |
Why?
|
Recurrence | 1 | 2007 | 8426 | 0.010 |
Why?
|
Homeostasis | 1 | 2006 | 3321 | 0.010 |
Why?
|
Patient Compliance | 1 | 2004 | 2688 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13248 | 0.010 |
Why?
|
Hospitalization | 1 | 2013 | 10708 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15250 | 0.010 |
Why?
|
Genes, Recessive | 1 | 1995 | 623 | 0.010 |
Why?
|
Survival Analysis | 1 | 2005 | 10072 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2006 | 3239 | 0.010 |
Why?
|
Chromosomes | 1 | 1995 | 578 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2006 | 3882 | 0.010 |
Why?
|
Electroencephalography | 1 | 2007 | 6240 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 1996 | 1994 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9310 | 0.010 |
Why?
|
Coronary Disease | 1 | 2005 | 5911 | 0.010 |
Why?
|
Genetic Markers | 1 | 1996 | 2601 | 0.010 |
Why?
|
Syndrome | 1 | 1995 | 3268 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2005 | 14599 | 0.010 |
Why?
|
Leptin | 1 | 1996 | 1595 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2006 | 20077 | 0.000 |
Why?
|
Incidence | 1 | 2004 | 21339 | 0.000 |
Why?
|
Alleles | 1 | 1995 | 6861 | 0.000 |
Why?
|
Adipose Tissue | 1 | 1996 | 3310 | 0.000 |
Why?
|
DNA | 1 | 1995 | 7196 | 0.000 |
Why?
|
Genotype | 1 | 1995 | 12977 | 0.000 |
Why?
|
Phenotype | 1 | 1995 | 16572 | 0.000 |
Why?
|
Mice | 1 | 1996 | 81368 | 0.000 |
Why?
|
Animals | 1 | 1996 | 168202 | 0.000 |
Why?
|